William A. Wallace, Ph.D. (@WilliamWallace) header
William A. Wallace, Ph.D. (@WilliamWallace) profile picture

Product Developer Human Biology, Medicine & Health Technology Host of The Active Site podcast

Joined October 2014
Photo by William A. Wallace, Ph.D. (@WilliamWallace)Photo by William A. Wallace, Ph.D. (@WilliamWallace)Photo by William A. Wallace, Ph.D. (@WilliamWallace)Photo by William A. Wallace, Ph.D. (@WilliamWallace)Photo by William A. Wallace, Ph.D. (@WilliamWallace)Photo by William A. Wallace, Ph.D. (@WilliamWallace)Photo by William A. Wallace, Ph.D. (@WilliamWallace)Photo by William A. Wallace, Ph.D. (@WilliamWallace)Photo by William A. Wallace, Ph.D. (@WilliamWallace)Photo by William A. Wallace, Ph.D. (@WilliamWallace)
After 65, about 60 minutes of brisk activity a week went with a 20% lower risk of coronary heart disease, a drop that took 330 minutes a week in people under 65. More than 80,000 UK adults wore a wrist tracker for a week and were followed for a median of almost eight years, during which 3,764 developed coronary heart disease. Meeting the 150-minute weekly guideline went with 28% lower risk in people 65 and older, against 15% in those younger. Older adults who packed their activity into one or two days, the so-called weekend warriors, had 28% lower risk, similar to those active through the week, while the pattern was weaker and not significant in midlife. Older adults also reached a given benefit at about half the movement intensity. This fits an earlier analysis of the same UK cohort, which found that weekend-warrior activity lowered heart attack risk about as much as spreading it through the week. A likely reason is the starting point. Fitness and muscle fall with age, so the same walk is a bigger relative effort at 70 than at 45, and a bigger stimulus for the heart and blood vessels. This was observational, and older adults who stay active may already be healthier in ways the tracker cannot see. One week of tracking stood in for years of habits. In older adults the benefit curve may have bent back at very high volumes, so more was not always better. References 1. Chen J, et al. J Am Heart Assoc. 2026:e052019. 2. Khurshid S, et al. JAMA. 2023;330(3):247-252.
4
10
1
57
1,552
People whose single hardest minute of movement each day was more intense had 42% lower mortality, even after accounting for how much they moved in total. More than 65,000 German adults aged 19 to 74 wore a hip movement tracker and were followed for a median of eight years, during which 1,634 died. More total movement went with 27% lower mortality. On top of that, the intensity of the most active minutes of the day mattered, and the shorter the window, the stronger the link: 42% lower mortality for the hardest single minute, against 31% for the hardest two hours. When those minutes had to come in one continuous bout, the links were weaker, 29% and 17%, so scattered bursts through the day tracked better than one long session. This echoes a UK tracker study in people who did no formal exercise, where about three short vigorous bursts a day, such as fast stair climbing or hurried walking, went with 38 to 40% lower mortality. A possible mechanism is that short, hard efforts push the heart, lungs and muscles close to their limits, which is the signal that builds aerobic fitness, one of the strongest predictors of how long people live. This was observational. Healthier, fitter people can reach higher peaks, so peak intensity may partly be a marker of fitness rather than a cause of it. One week of tracking stood in for habits across eight years, and the pattern differed by how much people moved overall. References 1. Fromherz P, et al. BMC Med. 2026;24(1):636. 2. Stamatakis E, et al. Nat Med. 2022;28(12):2521-2529.
1
11
1
69
1,898
Adding 15 minutes in a sauna after each workout cut LDL particles more than eight weeks of exercise alone did. In a trial, 47 sedentary adults who did not use saunas were randomly assigned to exercise three times a week, the same exercise followed by a 15-minute sauna, or no change. Blood tests counted and sized lipoprotein particles. Compared with exercise alone, the sauna group ended with fewer LDL particles, a lower LDL concentration, fewer of the triglyceride-rich VLDL particles, and larger HDL particles. In a separate group of regular sauna users, a single 30-minute session lowered triglycerides and raised ketones afterward. An earlier report from the same trial found that the sauna group's top blood pressure number was 8 points lower than the exercise-only group's, and their fitness was higher on a treadmill oxygen test. Long-running Finnish cohorts have linked frequent sauna use with fewer deaths from heart disease. A possible mechanism is heat stress acting like extra exercise. Heat raises heart rate and blood flow, triggers heat-shock proteins, and pushes the body to burn more fat, which may speed clearance of triglyceride-rich particles that later become LDL. The trial was small, and the new report says which way each marker moved but not by how much. Particle number is a risk marker, and no heart attacks or strokes were counted. Saunas are not advised for people with unstable heart disease or very low blood pressure without medical advice. References 1. Laukkanen JA, et al. Mayo Clin Proc. 2026. Published online November 12, 2026. 2. Lee E, et al. Am J Physiol Regul Integr Comp Physiol. 2022;323(3):R289-R299. 3. Laukkanen T, et al. JAMA Intern Med. 2015;175(4):542-548.
4
20
3
108
3,261
Sources: Laukkanen et al., Mayo Clin Proc 2026: doi.org/10.1016/j.mayocp.202… Lee et al., Am J Physiol Regul Integr Comp Physiol 2022: doi.org/10.1152/ajpregu.0007… Laukkanen et al., JAMA Intern Med 2015: doi.org/10.1001/jamainternme… doi.org/10.1016/j.mayocp.202…
421
Arginine in your diet may decide whether your immune system can see cancer. Cells display fragments of what is inside them on a surface protein called MHC class I, and killer T cells read that display to find cells that are infected or turning cancerous. Arginine, an amino acid found in meat, fish, dairy, nuts and beans, often runs low inside tumors and during infections. In cells, low arginine cut MHC class I production. In mice, an arginine-poor diet led to more colon tumors and weaker defense against influenza and SARS-CoV-2, while extra dietary arginine raised MHC class I levels, reduced tumors and improved infection outcomes. The mechanism is unusually specific. The genes for MHC class I lean on arginine codons that depend on a small set of transfer RNAs, and when arginine runs short those transfer RNAs drop, so cells stop building the protein. Changing those codons without changing the protein removed the effect, and the benefit disappeared in mice unable to put MHC class I on their surface. This builds on earlier work showing that higher arginine helps T cells survive longer and fight tumors better in mice. All of this is cells and mice. Whether arginine works this way in people has not been tested, and tumors can also feed on amino acids, so this is a reason for human trials, not a reason to start taking arginine. References 1. Wu Q, et al. Cell. 2026;189(19):6012-6023. 2. Geiger R, et al. Cell. 2016;167(3):829-842.
11
51
2
253
7,238
GLP-1 drugs prevented type 2 diabetes about a third better than metformin. In adults with prediabetes and obesity, starting a GLP-1 drug instead of metformin went with a 31% lower risk of type 2 diabetes over about three years. The study, a conference abstract presented this month and not yet peer reviewed, used health records from 104 institutions. About 128,000 people who started a GLP-1 drug were matched with the same number who started metformin, on age, health conditions, medications and lab values. Over follow-up, 25.1% of the GLP-1 group developed diabetes against 37.0% on metformin, and the GLP-1 group was about 1.5 times as likely to return to normal blood sugar. Heart failure, stroke, heart attack and atrial fibrillation were all less common, and deaths from any cause were 41% lower. For context, the landmark 2002 prevention trial found metformin cut new diabetes by 31% against placebo, and an intensive lifestyle program cut it by 58%. The likely mechanism is weight. GLP-1 drugs mimic a gut hormone that curbs appetite, slows stomach emptying and boosts insulin release after meals, and they usually cause far more weight loss than metformin, which mainly reduces glucose output from the liver. The size of the death gap is a warning sign. In a large randomized trial of semaglutide in people with heart disease, deaths from any cause were 19% lower, so a 41% gap here suggests the groups differed in ways the matching missed, such as insurance, access or overall health. The records did not show dose or whether people kept taking the drugs, and diagnoses came from billing codes. Only a randomized trial can settle this. References 1. Serra VDSB, et al. Circulation. 2026;154(suppl 1):8911. 2. Knowler WC, et al. N Engl J Med. 2002;346(6):393-403. 3. Lincoff AM, et al. N Engl J Med. 2023;389(24):2221-2232.
14
16
7
79
2,709
Lifting weights eased depression for about two out of three people. A new pooled analysis of 80 randomized trials covered 6,123 people with an average age of 57, most of them living with an illness. Compared with doing nothing, someone who lifted had about a 65 in 100 chance of ending up less depressed, where 50 in 100 would be a coin toss. Against other active programs such as aerobic exercise, stretching, relaxation or health education, lifting still came out ahead, though the edge was smaller, about 56 in 100. In people with a mental illness, that edge grew to about 61 in 100. An earlier review of 33 trials reached a similar conclusion in 2018. Several mechanisms are plausible. Training raises growth factors in the brain, dampens inflammatory signaling, improves sleep, and gives a measurable sense of progress as weights go up. Which of these matters most is not known. Results varied widely between trials, and nobody can be blinded to whether they are lifting. The most carefully run trials showed a smaller benefit, about 59 in 100. Lifting may help alongside therapy or medication, but it is not a substitute for care in moderate or severe depression. References 1. O'Sullivan D, et al. JAMA Netw Open. 2026;9(11):e2644254. 2. Gordon BR, et al. JAMA Psychiatry. 2018;75(6):566-576.
6
29
2
142
3,173
A daily drink of three common fibers lowered androgens and restored ovulation in women with PCOS within 12 weeks. In a Canadian study, women with PCOS ate the same calories as women without it but less fiber, about 20 grams a day against 25, and those eating the least had higher insulin resistance and testosterone. In a trial in Iran, 20 grams a day of a fiber called resistant dextrin for three months lowered free testosterone and made cycles more regular. A new Science trial from Beijing gave women with PCOS a blend of inulin, resistant starch and beta-glucan or a look-alike placebo drink for 12 weeks. Androgens, the male-type hormones that drive many PCOS symptoms, fell in the fiber group, and ovulation and menstrual cycles improved. The mechanism runs through the gut. The fiber fed a bacterium called Bacteroides xylanisolvens, which converts the androgen androstenedione into a much weaker compound, and other gut bacteria break that down further. Women with more of this bacterium had lower androgens. The same fibers are in oats, barley, onions, garlic, cooled potatoes and green bananas. This was one 12-week trial at a single hospital in China, the three fibers were given together, and the bacterium's role was confirmed only in mice. References 1. Qi X, et al. Science. 2026;394(6824):eaed8952. 2. Cutler DA, et al. Food Sci Nutr. 2019;7(4):1426-1437. 3. Gholizadeh Shamasbi S, et al. Eur J Nutr. 2019;58(2):629-640.
2
16
1
110
3,593
Inflammation was supposed to be the next cholesterol. In 2017, CANTOS showed that blocking interleukin-1 beta cut heart attacks, strokes and cardiovascular deaths by about 15% without touching LDL. CRP started to look like a second number to measure and lower. Then ZEUS, a new trial in the New England Journal of Medicine, dropped CRP by almost 90%. What happened to heart attacks is the part that matters. youtu.be/OjfZrFyjUCk?is=1dhM…
8
1
59
2,601
In healthy adults, blood NAD held steady from age 18 to 65, and it ran low in people with heart disease and high blood pressure. NAD is a molecule every cell uses to turn food into energy and to repair DNA, and the idea that it drains away with age is the main sales pitch for NAD boosters. A Lithuanian team writing in Nature Metabolism tested that idea with finger-prick blood taken after an overnight fast from 1,068 adults. In healthy men, NAD stayed flat across adult ages. In healthy women, it rose slightly with age. It was lower in people with cardiovascular disease and high blood pressure. A separate Nature Metabolism study from May, using a different lab method across seven separate cohorts, also found blood NAD stable with age and unchanged by lifestyle programs. One possible mechanism is demand. Chronic inflammation and vascular damage switch on enzymes such as CD38 and PARPs that use up NAD faster than cells can rebuild it, so low blood NAD may be a sign of the disease rather than of the calendar. Blood is not muscle, brain or skin, which may still lose NAD with age. A single blood draw also cannot show that low NAD causes heart disease or that raising it would help. References 1. Romenskaja-Avgul D, et al. Nat Metab. 2026. 2. Trętowicz M, et al. Nat Metab. 2026;8(6):1282-1290.
3
12
74
2,172
For decades, cholesterol has been blamed for heart disease, but some have argued that inflammation is the real culprit. In 2017, that idea got what looked like proof when a drug cut heart attacks by calming inflammation while cholesterol stayed exactly where it was. A major cardiology group now recommends testing everyone's inflammation level alongside their cholesterol. Then, in November 2026, the biggest test yet of that idea reported its results. This investigation follows the evidence from inside the artery wall to that trial to find out whether inflammation really is the new cholesterol. youtube.com/watch?v=OjfZrFyj…
8
15
1
77
4,054
Twelve weeks of a low-calorie diet plus supervised training put 54% of adults under 45 with type 2 diabetes into remission, compared with 4% on usual care. In the RESET for Remission trial, adults aged 18 to 45 with type 2 diabetes and obesity ate 800 to 900 calories a day, mostly as meal-replacement shakes, and trained three times a week, twice with an exercise physiologist. Their diabetes drugs were stopped at the start under medical supervision. At 24 weeks, 27 of 50 were in remission, meaning an HbA1c below the diabetes cutoff with no glucose-lowering drugs, against 2 of 46 on usual care. The program group lost about 7.5 kilograms more, roughly 6.5 of it fat, while muscle volume held and grip strength rose. This fits the earlier DiRECT trial, where a similar diet without supervised training put 46% of adults into remission at one year, against 4% of controls. A likely reason is fat leaving the liver and pancreas. Liver fat fell sharply here, and less fat in the pancreas may let insulin-making cells recover. Training protects muscle, the body's main place to clear sugar. The trial was open-label, lasted only 24 weeks, and had no diet-only group. Early side effects such as constipation and headache were common, so this needs a medical team, not a solo attempt.
6
31
2
126
3,348
Sources: Dasgupta et al., Lancet Reg Health Am 2026: doi.org/10.1016/j.lana.2026.… Lean et al., Lancet 2018: doi.org/10.1016/S0140-6736(1…
2
369